Go to the profile of InRegen

InRegen

CEO, InRegen

About InRegen

n over 50 years there was little development in the treatment of chronic kidney disease. At inRegen we are pioneers in the field of Chronic kidney treatment.

Therapeutic Areas

Genitourinary

Technologies

Regenerative medicine

Company Type

Biotechnology – Therapeutics

State of Ownership

Private

Sponsorship Group

Networker

Topics

Editions participated in:

June 2020